BNGO
Price
$3.67
Change
-$0.08 (-2.13%)
Updated
Jun 9, 04:59 PM (EDT)
Capitalization
57.43M
MBOT
Price
$2.49
Change
-$0.32 (-11.39%)
Updated
Jun 9, 04:59 PM (EDT)
Capitalization
18.57M
64 days until earnings call
Interact to see
Advertisement

BNGO vs MBOT

Header iconBNGO vs MBOT Comparison
Open Charts BNGO vs MBOTBanner chart's image
Bionano Genomics
Price$3.67
Change-$0.08 (-2.13%)
Volume$700
Capitalization57.43M
Microbot Medical
Price$2.49
Change-$0.32 (-11.39%)
Volume$11.91K
Capitalization18.57M
BNGO vs MBOT Comparison Chart
Loading...
BNGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MBOT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BNGO vs. MBOT commentary
Jun 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BNGO is a StrongBuy and MBOT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 10, 2025
Stock price -- (BNGO: $3.70 vs. MBOT: $2.83)
Brand notoriety: BNGO and MBOT are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BNGO: 37% vs. MBOT: 214%
Market capitalization -- BNGO: $57.43M vs. MBOT: $18.57M
BNGO [@Medical Specialties] is valued at $57.43M. MBOT’s [@Medical Specialties] market capitalization is $18.57M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BNGO’s FA Score shows that 1 FA rating(s) are green whileMBOT’s FA Score has 0 green FA rating(s).

  • BNGO’s FA Score: 1 green, 4 red.
  • MBOT’s FA Score: 0 green, 5 red.
According to our system of comparison, MBOT is a better buy in the long-term than BNGO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BNGO’s TA Score shows that 3 TA indicator(s) are bullish while MBOT’s TA Score has 4 bullish TA indicator(s).

  • BNGO’s TA Score: 3 bullish, 4 bearish.
  • MBOT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, MBOT is a better buy in the short-term than BNGO.

Price Growth

BNGO (@Medical Specialties) experienced а +2.21% price change this week, while MBOT (@Medical Specialties) price change was +11.42% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.37%. For the same industry, the average monthly price growth was +5.59%, and the average quarterly price growth was +1.68%.

Reported Earning Dates

MBOT is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Medical Specialties (+3.37% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BNGO($57.4M) has a higher market cap than MBOT($18.6M). MBOT YTD gains are higher at: 152.679 vs. BNGO (-78.618). MBOT has higher annual earnings (EBITDA): -10.75M vs. BNGO (-213.4M). BNGO has more cash in the bank: 102M vs. MBOT (8.15M). MBOT has less debt than BNGO: MBOT (245K) vs BNGO (79.4M). BNGO has higher revenues than MBOT: BNGO (36.1M) vs MBOT (0).
BNGOMBOTBNGO / MBOT
Capitalization57.4M18.6M309%
EBITDA-213.4M-10.75M1,985%
Gain YTD-78.618152.679-51%
P/E RatioN/AN/A-
Revenue36.1M0-
Total Cash102M8.15M1,251%
Total Debt79.4M245K32,408%
FUNDAMENTALS RATINGS
BNGO vs MBOT: Fundamental Ratings
BNGO
MBOT
OUTLOOK RATING
1..100
6422
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
47
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9999
PRICE GROWTH RATING
1..100
9335
P/E GROWTH RATING
1..100
89100
SEASONALITY SCORE
1..100
4838

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BNGO's Valuation (25) in the Biotechnology industry is in the same range as MBOT (47). This means that BNGO’s stock grew similarly to MBOT’s over the last 12 months.

BNGO's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as MBOT (100). This means that BNGO’s stock grew similarly to MBOT’s over the last 12 months.

BNGO's SMR Rating (99) in the Biotechnology industry is in the same range as MBOT (99). This means that BNGO’s stock grew similarly to MBOT’s over the last 12 months.

MBOT's Price Growth Rating (35) in the Biotechnology industry is somewhat better than the same rating for BNGO (93). This means that MBOT’s stock grew somewhat faster than BNGO’s over the last 12 months.

BNGO's P/E Growth Rating (89) in the Biotechnology industry is in the same range as MBOT (100). This means that BNGO’s stock grew similarly to MBOT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BNGOMBOT
RSI
ODDS (%)
N/A
Bearish Trend 13 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 13 days ago
73%
Bullish Trend 13 days ago
76%
Momentum
ODDS (%)
Bearish Trend 13 days ago
90%
Bullish Trend 13 days ago
83%
MACD
ODDS (%)
Bearish Trend 13 days ago
90%
Bearish Trend 13 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 13 days ago
90%
Bullish Trend 13 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 13 days ago
90%
Bullish Trend 13 days ago
72%
Advances
ODDS (%)
Bullish Trend 28 days ago
79%
Bullish Trend 13 days ago
72%
Declines
ODDS (%)
Bearish Trend 22 days ago
90%
Bearish Trend 20 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 13 days ago
85%
Bearish Trend 13 days ago
82%
Aroon
ODDS (%)
N/A
Bullish Trend 13 days ago
63%
View a ticker or compare two or three
Interact to see
Advertisement
BNGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MBOT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

BNGO and

Correlation & Price change

A.I.dvisor tells us that BNGO and ALGN have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BNGO and ALGN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BNGO
1D Price
Change %
BNGO100%
-1.86%
ALGN - BNGO
32%
Poorly correlated
+0.87%
MDT - BNGO
30%
Poorly correlated
+0.07%
MBOT - BNGO
30%
Poorly correlated
+4.81%
PACB - BNGO
29%
Poorly correlated
+20.85%
LMAT - BNGO
29%
Poorly correlated
-2.02%
More

MBOT and

Correlation & Price change

A.I.dvisor tells us that MBOT and POAI have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MBOT and POAI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MBOT
1D Price
Change %
MBOT100%
+4.81%
POAI - MBOT
33%
Poorly correlated
N/A
RCEL - MBOT
32%
Poorly correlated
+2.31%
BNGO - MBOT
30%
Poorly correlated
-1.86%
CODX - MBOT
30%
Poorly correlated
+16.47%
AIMD - MBOT
27%
Poorly correlated
+23.54%
More